Brugada syndrome: Risk stratification and prevention of sudden cardiac death

被引：2
作者：
Eckardt L. [1 ]
机构：
[1] Klinik für Kardiologie II – Rhythmologie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, Münster
来源：
Herzschrittmachertherapie + Elektrophysiologie | 2020年 / 31卷 / 1期
关键词：
Implantable cardioverter-defibrillator; Ion-channelopathy; Risk stratification; ST-segment elevations; Ventricular tachycardia;
D O I：
10.1007/s00399-020-00667-x
中图分类号：
学科分类号：
摘要：
Brugada syndrome is ion channelopathy defined by coved type ST-elevation in at least one right precordial ECG lead. Patients may suffer from ventricular tachycardia/fibrillation, which may cause syncope or sudden cardiac death. The majority of patients are likely to remain asymptomatic throughout life. A correct ECG diagnosis remains challenging. The implantable cardioverter/defibrillator (ICD) is the only established therapy to protect against sudden cardiac death. Thus, individual risk stratification is of major clinical relevance in primary prevention. The present article gives an update on current risk stratification and novel therapeutic options apart from ICD therapy. © 2020, Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码：39 / 47
页数：8
相关论文
共 36 条
  • [1] Brugada J., Campuzano O., Arbelo E., Sarquella-Brugada G., Brugada R., Present status of Brugada syndrome, J Am Coll Cardiol, 72, pp. 1046-1059, (2018)
  • [2] Watanabe H., Minamino T., Genetics of Brugada syndrome, J Hum Genet, 61, pp. 57-60, (2016)
  • [3] Bayes de Luna A., Brugada J., Baranchuk A., Borggrefe M., Breithardt G., Goldwasser D., Lambiase P., Riera A.P., Garcia-Niebla J., Pastore C., Oreto G., McKenna W., Zareba W., Brugada R., Brugada P., Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report, J Electrocardiol, 45, pp. 433-442, (2012)
  • [4] Osher H.L., Wolff L., Electrocardiographic pattern simulating acute myocardial injury, Am J Med Sci, 226, pp. 541-545, (1953)
  • [5] Chevallier S., Forclaz A., Tenkorang J., Ahmad Y., Faouzi M., Graf D., Schlaepfer J., Pruvot E., New electrocardiographic criteria for discriminating between Brugada types 2 and 3 patterns and incomplete right bundle branch block, J. Am. Coll. Cardiol., 58, pp. 2290-2298, (2011)
  • [6] Smits J.P., Eckardt L., Probst V., Bezzina C.R., Schott J.J., Remme C.A., Haverkamp W., Breithardt G., Escande D., Schulze-Bahr E., LeMarec H., Wilde A.A., Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients, J Am Coll Cardiol, 40, pp. 350-356, (2002)
  • [7] Catalano O., Antonaci S., Moro G., Mussida M., Frascaroli M., Baldi M., Cobelli F., Baiardi P., Nastoli J., Bloise R., Monteforte N., Napolitano C., Priori S.G., Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities, Eur Heart J, 30, pp. 2241-2248, (2009)
  • [8] Rolf S., Bruns H.J., Wichter T., Kirchhof P., Ribbing M., Wasmer K., Paul M., Breithardt G., Haverkamp W., Eckardt L., The ajmaline challenge in Brugada syndrome: diagnostic impact, safety and recommended protocol, Eur Heart J, 24, pp. 1104-1112, (2003)
  • [9] Frommeyer G., Eckardt L., Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms, Nat Rev Cardiol, 13, pp. 36-47, (2016)
  • [10] Brugada P., Brugada J., Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report, J Am Coll Cardiol, 20, pp. 1391-1396, (1992)
1234